News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
cnbc.com Balance sheet
Synchrony Financial, the credit card issuer for brands including Amazon, Walmart and Lowe's, is working with OpenAI to allow shoppers to buy products directly inside ChatGPT using their store cards. The deal is one of the first major moves by a U.S. consumer lender to bring financing, payments and rewards directly into an AI chatbot. While agentic commerce …
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
The Aug. 17 report arrives with the stock flat on the week but still under pressure over the past month.
GSA Capital Partners LLP recently acquired a new stake in Synchrony Financial (NYSE:SYF), purchasing 62,159 shares valued at approximately $4.73 million, making it their 16th largest holding. Other institutional investors have also adjusted their positions in the company. Synchrony Financial has received a "Moderate …
Empowered Funds LLC significantly reduced its stake in Synchrony Financial by 68.1% in the first quarter, selling over 205,000 shares but still holding 95,823 shares valued at $6.52 million. Despite this reduction, institutional investors collectively own 96.48% of SYF, and analysts maintain a positive …
Alistair N Sporck, VP of Contactor Business Unit at Aehr Test Systems (NASDAQ:AEHR), sold 1,000 shares of common stock for $108,490. This transaction occurred on August 10, 2026, with each share priced at $108.49. Following the sale, Sporck still directly holds 22,547 shares and …
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) for alleged violations of federal securities laws. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing …
Jefferies Financial Group has upgraded Aehr Test Systems (NASDAQ:AEHR) to a "strong-buy" rating, joining other analysts in a bullish outlook, with a consensus price target of $136.67. The company's stock opened at $134.06 and is near its 52-week high, supported by recent AI-related orders …
Penn Capital Management Company LLC has made a new investment in Aehr Test Systems (NASDAQ:AEHR), acquiring 150,547 shares worth approximately $14.5 million, giving it a 0.46% stake. Institutional investors now own 69.69% of the company, which has an average "Buy" rating and a $136.67 …
Archrock (AROC) recently reported strong second-quarter results, with increased net income despite lower revenue, and raised its full-year 2026 net income guidance to US$290.75 million–US$310.75 million. The company also indicated capacity for acquisitions, adding a new dimension to its investment narrative. While analysts show …
Aehr Test Systems director Rhea J. Posedel sold 5,973 shares of the company's common stock for a total of $836,220 on August 14, 2026. This transaction occurred near the stock's 52-week high after a significant surge in value. Following the sale, Posedel retains substantial …
Archrock Inc (AROC) shares rallied 4.0%, reaching $34.69, but GuruFocus' GF Value indicates the stock is 26.7% overvalued at $27.39. Despite a strong GF Score of 85/100, insider selling of $5.9 million over the last three months, without any buying, suggests caution for investors. …
Nephros Inc. director Arthur H. Amron was granted 2,418 shares of Common Stock on August 12, 2026, as compensation for his board service, increasing his direct holdings to 140,874 shares. He also holds stock options for 7,323 shares fully vested at an exercise price …
AWM Investment Company, Inc. has filed an amended Schedule 13G disclosing a beneficial ownership of 374,808 shares of AEHR Test Systems' common stock, representing 1.1% of the class. The shares are held across four Special Situations funds, with AWM exercising sole voting and dispositive …
Northland Securities has reiterated its Hold rating on Nephros (NEPH.US) but raised the price target to $4.75. This adjustment indicates a slightly more optimistic outlook on the company's future stock performance by the firm.
UBS has assumed coverage on Schrodinger (SDGR), raising its price target from $13.00 to $19.00, while maintaining a Neutral rating. GuruFocus indicates SDGR is currently undervalued by 29.0% with a GF Value™ of $25.03 and has a moderately favorable GF Score™ of 73/100, though …
UBS has reiterated its Hold rating on Schrodinger (SDGR.US) and maintained its target price at $19. This indicates that the firm does not anticipate significant upward or downward movement for the stock in the near term, based on its current analysis.
This article highlights three promising penny stocks for August 2026: Nephros (NEPH), Siebert Financial (SIEB), and Douglas Elliman (DOUG). It examines their financial health, recent performance, and strategic initiatives, noting that these companies offer potential for growth despite being smaller or newer entities. The …
Search by ticker symbol or company name and select a result to open its chart.